EXHIBIT 21.1
SUBSIDIARIES OF FORTRESS BIOTECH, INC.
Subsidiaries of Fortress Biotech, Inc. at December 31, 2017,
with jurisdiction of incorporation or formation:
| • | Aevitas Therapeutics, Inc. (Delaware) |
| • | Avenue Therapeutics, Inc. (Delaware)’ |
| • | Caelum Biosciences, Inc. (Delaware), formerly FBIO Acquisition Corp. II |
| • | CB Securities Corporation (Massachusetts) |
| • | Cellvation Inc. (Delaware), formerly FBIO Acquisition Corp. I |
| • | Checkpoint Therapeutics, Inc. (Delaware) |
| • | Cyprium Therapuetics, Inc. (Delaware) |
| • | Coronado SO Co. (Delaware) |
| • | Escala Therapeutics, Inc., formerly Altamira Biosciences, Inc. (Delaware) |
| • | FBIO Acquisition Corp. IV, VI – XIV (Delaware) |
| • | GeneXion Oncology, Inc. (Delaware), formerly FBIO Acquisition Corp. III |
| • | Helocyte, Inc., formerly DiaVax Biosciences, Inc. (Delaware) |
| • | Innmune Limited (United Kingdom) |
| • | Journey Medical Corporation (Delaware) |
| • | Mustang Bio, Inc. (Delaware) |
| • | National Holdings Corporation (Delaware). |
| • | Tamid Bio, Inc. (Delaware), formerly FBIO Acquisition Corp. V |